Justin H. Johannesen
Robert J. Morgan
Mohammed M. Algodi
Carlos A. Gongora
<p><span style="color: rgba(0, 0, 0, 0.9); font-family: -apple-system, system-ui, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', 'Fira Sans', Ubuntu, Oxygen, 'Oxygen Sans', Cantarell, 'Droid Sans', 'Apple Color Emoji', 'Segoe UI Emoji', 'Segoe UI Emoji', 'Segoe UI Symbol', 'Lucida Grande', Helvetica, Arial, sans-serif;">Carlos A Gongora MD is a Cardiologist, Cardio-Oncologist, Cardiac Imager, and Researcher at Montefiore Medical Center. He is a physician educated in Mexico and a graduate of the Faculty of Medicine at the Benemerita Universidad Autonoma de Puebla (BUAP). After studying at the BUAP he worked for 1 year as a primary care physician at a rural clinic in a small community in Puebla, Mexico. After that, he moved to the USA and worked as a program coordinator in a public health project in Boston, MA, promoting cardiovascular health and healthy eating. Then, he completed two years of cardiovascular research at the Cardiovascular Research Foundation, where he published and presented his research in various international conferences and received an award of excellence for his research. He finished his Cardiology fellowship in June of 2020 at Mount Sinai West and Morningside Hospitals. During his residency and fellowship, he continued with his cardiovascular research and has worked in a public health program in the Bronx. Also, during his cardiology fellowship he developed, presented and published different cardiovascular research projects. Due to his hard work, he was chosen as Chief Cardiology Fellow. During the beginning of the COVID-19 pandemic in New York City, Dr. Gongora took care of critically ill COVID-19 patients with cardiac comorbidities in the Cardiac Care Unit. He participated in international conferences to discuss the latest observations, advances and therapies in hospitalized patients with COVID-19. He lastly finished an Advanced Cardiac Imaging and Cardio-Oncology Fellowship at the Massachusetts General Hospital and Harvard Medical School. Also he completed courses in Epidemiology and Biostatistics at the Harvard School of Public Health. While in Boston, Dr. Gongora has been involved in projects focusing on cardiotoxicity associated with immune therapies and anthracyclines among patients with cancer. Additionally, he has worked on projects focusing on medical therapy for patients with COVID-19 and their cardiac involvement.</span></p>
Aryeh Z. Abelow
Lili Zhang
Non-invasive cardiology, echocardiography, cardio-oncology, multimodality cardiovascular imaging
Cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, and the application of multimodality imaging and machine-learning techniques in cardiovascular disease.
<p>Lili Zhang, MD, is Director, Cardio-Oncology Program and Assistant Professor, Cardiology at Montefiore Einstein. A non-invasive cardiologist and a cardiac imaging specialist, Dr. Zhang’s clinical focus is in Cardio-Oncology, cardiomyopathy, general cardiology, echocardiography and multimodality cardiac imaging.</p><p>In 2007, Dr. Zhang earned her Doctor of Medicine degree at Peking University, Beijing, China. Further education and postdoctoral training brought her to the U.S., completing her Master of Science in Epidemiology at Johns Hopkins Bloomberg School of Public Health in 2011. She then came to Einstein, completing her residency in internal medicine in 2015 and her fellowship in cardiology in 2018. In 2019, Dr. Zhang completed her fellowship in Cardio-Oncology and cardiac imaging at Massachusetts General Hospital.</p><p>Dr. Zhang’s research focuses on cardiotoxicity of cancer therapy, immune checkpoint inhibitor myocarditis, cardiovascular care and the application of multimodality imaging and machine-learning techniques in cardiovascular disease. Her research experience includes retrospective studies, prospective cohorts (ARIC and CHS), large multi-cohort consortiums (CHARGE and PAGE consortiums), randomized clinical trials (PROMISE trial), and international collaborative registries (international immune checkpoint inhibitor myocarditis registry and Global Cardio Oncology Registry). She has shared her work through more than 60 manuscripts in peer-reviewed journals and abstract publications.</p><p>Dr. Zhang is board certified in Internal Medicine and Cardiovascular Disease. She is a Fellow of the American College of Cardiology, and is a member of the American Heart Association and the international Cardio-Oncology Society. In 2021, she was awarded the Glorney-Raisbeck Junior Faculty Research Award in Cardiovascular Disease by New York Academy of Medicine.</p>
Heather A. Trivedi
<p>Non-invasive imaging including transthoracic and transesophageal  echocardiography; stress testing; clinical cardiology; women's health. </p>
Jooyoung (Julia) Shin
<p align="left" style=" word-break: normal; text-align: left;"><span style=" color: black; font-size: 12.0pt; font-family: 'Times New Roman';">Clinical cardiology, specifically end-stage congestive heart failure, mechanical circulatory support, and cardiac transplantation.  </span></p>
Dr. Shin's clinical focus is on caring for patients with heart failure, particularly providing expertise in advanced heart failure, heart transplantation, and mechanical circulatory support.
Heart failure treatment is the primary focus of Dr. Shin’s research. She is the site principal investigator for the effectiveness of omecamtiv mecarbil/AMG 423 to treat chronic heart failure with reduced ejection fraction (GALACTIC-HF) and multiple cardiac sensors for the management of heart failure (MANAGE-HF) trials.
<p>Jooyoung Julia Shin, MD, is Fellowship Director, Advanced Heart Failure and Transplant Cardiology Fellowship Program and Associate Professor, Medicine at Montefiore Einstein. Dr. Shin’s clinical focus centers on heart failure, cardiac transplantation and mechanical circulatory support.</p><p>After obtaining her Bachelor of Science from the University of Michigan in 1994, Dr. Shin earned her Doctor of Medicine at George Washington University in 1999. She completed an internship and residency in internal medicine at the University of Maryland in 2002 before completing a cardiovascular disease fellowship at Emory University in 2005. Following this, Dr. Shin remained at Emory to complete an additional fellowship in advanced heart failure and transplant cardiology in 2006.</p><p>Dr. Shin’s research focuses on fellow education. She has been principal investigator and co-principal investigator on several funded research projects, and she has presented at invited lectures nationwide. Her work has also been published in numerous peer-reviewed journals, and she has been a reviewer for scientific publications, including the <em>Mayo Clinic Proceedings</em>, the <em>American Journal of Cardiology</em> and <em>Pacing and Clinical Electrophysiology</em>, among others.</p><p>Dr. Shin is board certified by the American Board of Internal Medicine in Cardiovascular Disease, Internal Medicine and Advanced Heart Failure and Transplant Cardiology. She is a member of the American College of Cardiology and the International Society for Heart and Lung Transplantation.</p>